Design of magnetic nanoparticles-assisted drug delivery system

Current Pharmaceutical Design

Volumn 17, Issue 22, 2011, Pages 2331-2351

  Chen, Guo Jing ^a   Wang, Li Fang ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Drug delivery; Magnetic nanoparticles; Nanotechnology; Superparamagnetic iron oxide; Surface modification; Targeting therapy

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CARRAGEENAN; DOXORUBICIN; DRUG CARRIER; ELASTIN; FERRIC OXIDE; FERROUS CHLORIDE; FOLIC ACID; GONADORELIN; IRON OXIDE; MAGNETIC NANOPARTICLE; MONOCLONAL ANTIBODY; MONOMER; N SUCCINIMIDYL 3 (2 PYRIDYLDITHIO) PROPIONATE; NANOCOATING; NANOSHELL; PLASMID DNA; POLYETHYLEIMINE; POLYMER; POLYOL; PREDNISONE ACETATE; PROPIONIC ACID DERIVATIVE; SMALL INTERFERING RNA; STABILIZING AGENT; TRANSFERRIN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ARTICLE; BIOMEDICAL ENGINEERING; CANCER GENE THERAPY; CONSTRAINED ENVIRONMENT; DECOMPOSITION; DNA VECTOR; DRUG DELIVERY SYSTEM; DRUG TARGETING; ELECTROCHEMICAL ANALYSIS; FLAME METHOD; FLOW INJECTION ANALYSIS; GEL; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; MECHANICAL MILLING; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHOTOCHEMISTRY; PRECIPITATION; PRIORITY JOURNAL; SONOCHEMICAL SYNTHESIS; SURFACE PROPERTY; SYNTHESIS; THERMAL REACTION;

DRUG CARRIERS; GENE TRANSFER TECHNIQUES; MAGNETITE NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SURFACE PROPERTIES;

EID: 80052230356     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211797052574     Document Type: Article

References (337)

1. Whitesides GM. The 'right' size in nanobiotechnology. Nat Biotechnol 2003; 21: 1161-5.
2. Islam T, Josephson L. Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles. Cancer Biomark 2009; 5: 99-107.
3. Weissleder R, Bogdanov A, Neuwelt EA, Papisov M. Longcirculating iron oxides for MR imaging. Adv Drug Deliv Rev 1995; 16: 321-34.
4. Briley-Saebo K, Bjornerud A, Grant D, Ahlstrom H, Berg T, Kindberg GM. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res 2004; 316: 315-23.
5. Hykrdova L, Jirkovsky J, Grabner G, Mailhot G, Bolte M. Degradation of supramolecular complexes photoinduced by iron(III): the influence of the host on the reactivity of the guest. Photochem Photobiol Sci 2003; 2: 163-70.
6. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11: 2319-31.
7. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. J Drug Target 1998; 6: 167-74.
8. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-9.
9. Sun S, Murray CB, Weller D, Folks L, Moser A. Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science 2000; 287: 1989-92.
10. Miller MM, Prinz GA, Cheng SF, Bounnak S. Detection of a micron-sized magnetic sphere using a ring-shaped anisotropic magnetoresistance-based sensor: A model for a magnetoresistancebased biosensor. Appl Phys Lett 2002; 81: 2211-3.
11. Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm 2005; 2: 194-205.
12. Bulte JW. Intracellular endosomal magnetic labeling of cells. Methods Mol Med 2006; 124: 419-39.
13. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995-4021.
14. McCarthy JR, Kelly KA, Sun EY, Weissleder R. Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine 2007; 2: 153-67.
15. Duguet E, Vasseur S, Mornet S, Devoisselle JM. Magnetic nanoparticles and their applications in medicine. Nanomedicine 2006; 1: 157-68.
16. Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN. Iron Oxide Based MR Contrast Agents: from Chemistry to Cell Labeling. Curr Med Chem 2009; 16: 4712-27.
17. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-110.
18. Massart R. Preparation of Aqueous Magnetic Liquids in Alkaline and Acidic Media. IEEE Trans Magn 1981; 17: 1247-8.
19. Jolivet JP, Chaneac C, Tronc E. Iron oxide chemistry. From molecular clusters to extended solid networks. Chem Commun (Camb) 2004: 481-7.
20. Karaagac O, Kockar H, Beyaz S, Tanrisever T. A Simple Way to Synthesize Superparamagnetic Iron Oxide Nanoparticles in Air Atmosphere: Iron Ion Concentration Effect. IEEE Trans Magn 2010; 46: 3978-83.
21. Iwasaki T, Mizutani N, Watano S, Yanagida T, Kawai T. Size control of magnetite nanoparticles by organic solvent-free chemical coprecipitation at room temperature. J Exper Nanosci 2010; 5: 251-62.
22. Yazdani F, Edrissi M. Effect of pressure on the size of magnetite nanoparticles in the coprecipitation synthesis. Mater Sci Eng BAdv Funct Solid State Mater 2010; 171: 86-9.
23. Dresco PA, Zaitsev VS, Gambino RJ, Chu B. Preparation and properties of magnetite and polymer magnetite nanoparticles. Langmuir 1999; 15: 1945-51.
24. Santra S, Tapec R, Theodoropoulou N, Dobson J, Hebard A, Tan W. Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: The effect of nonionic surfactants. Langmuir 2001; 17: 2900-6.
25. Uchida M, Flenniken ML, Allen M, et al. Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J Am Chem Soc 2006; 128: 16626-33.
26. Bonacchi D, Caneschi A, Dorignac D, et al. Nanosized iron oxide particles entrapped in pseudo-single crystals of γ-cyclodextrin. Chem Mater 2004; 16: 2016-20.
27. Hou Y, Kondoh H, Shimojo M, et al. Inorganic nanocrystal selfassembly via the inclusion interaction of beta-cyclodextrins: toward 3D spherical magnetite. J Phys Chem B 2005; 109: 4845-52.
28. Sangregorio C, Wiemann JK, O'Connor C J, Rosenzweig Z. A new method for the synthesis of magnetoliposomes. J Appl Phys 1999; 85: 5699-701.
29. De Cuyper M, Joniau M. Magnetoliposomes. Formation and structural characterization. Eur Biophys J 1988; 15: 311-9.
30. Soenen SJ, Hodenius M, De Cuyper M. Magnetoliposomes: versatile innovative nanocolloids for use in biotechnology and biomedicine. Nanomedicine (Lond) 2009; 4: 177-91.
31. Yu WW, Falkner JC, Yavuz CT, Colvin VL. Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts. Chem Commun (Camb) 2004: 2306-7.
32. Rockenberger J, Scher EC, Alivisatos AP. A new nonhydrolytic single-precursor approach to surfactant-capped nanocrystals of transition metal oxides. J Am Chem Soc 1999; 121: 11595-6.
33. Guardia P, Perez-Juste J, Labarta A, Batlle X, Liz-Marzan LM. Heating rate influence on the synthesis of iron oxide nanoparticles: the case of decanoic acid. Chem Commun 2010; 46: 6108-10.
34. Guardia P, Perez N, Labarta A, Batlle X. Controlled Synthesis of Iron Oxide Nanoparticles over a Wide Size Range. Langmuir 2010; 26: 5843-7.
35. Yin M, O'Brien S. Synthesis of monodisperse nanocrystals of manganese oxides. J Am Chem Soc 2003; 125: 10180-1.
36. Li Z, Wei L, Gao MY, Lei H. One-pot reaction to synthesize biocompatible magnetite nanoparticles. Adv Mater 2005; 17: 1001-5.
37. Yang H, Zhang CX, Shi XY, et al. Water-soluble superparamagnetic manganese ferrite nanoparticles for magnetic resonance imaging. Biomaterials 2010; 31: 3667-73.
38. Kumar K, Hsu HL, Selvin R. A facile method for the synthesis of magnetite nanocrystals. Optoelectron Adv Mater-Rapid Commun 2010; 4: 1628-30.
39. Sun S, Zeng H, Robinson DB, et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004; 126: 273-9.
40. Lu Y, Yin Y, Mayers BT, Xia Y. Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach. Nano Lett 2002; 2; 183-6.
41. Dai Z, Meiser F, Mohwald H. Nanoengineering of iron oxide and iron oxide/silica hollow spheres by sequential layering combined with a sol-gel process. J Colloid Interface Sci 2005; 288: 298-300.
42. 3/SiO2 nanocomposites. Acta Mater 2001; 49: 2805-11.
43. 3 Nanoparticles Dispersed over a Silica Matrix. J Phys Chem B 1998; 102: 7721-6.
44. Raileanu M, Crisan M, Petrache C, et al. Sol-gel FexOy-SiO2 nanocomposites. Rom J Phys 2005; 50: 595-606.
45. Zhang M, Cheng D, He XW, Chen LX, Zhang YK. Magnetic Silica-Coated Sub-Microspheres with Immobilized Metal Ions for the Selective Removal of Bovine Hemoglobin from Bovine Blood. Chem Asian Journal 2010; 5: 1332-40.
46. Parida KM, Pradhan GK. Sol-gel synthesis and characterization of mesoporous iron-titanium mixed oxide for catalytic application. Mater Chem Phys 2010; 123: 427-33.
47. Wu W, Xiao XH, Zhang SF, Li H, Zhou XD, Jiang CZ. One-Pot Reaction and Subsequent Annealing to Synthesis Hollow Spherical Magnetite and Maghemite Nanocages. Nanoscale Res Lett 2009; 4: 926-31.
48. Park CD, Walker J, Tannenbaum R, Stiegman AE, Frydrych J, Machala L. Sol-Gel-Derived Iron Oxide Thin Films on Silicon: Surface Properties and Interfacial Chemistry. ACS Appl Mater Interfaces 2009; 1: 1843-6.
49. 3 nanoparticle size. Morphology, microstructure, and magnetic behavior. Chem Mater 1999; 11: 141-7.
50. Vulićević1 L, Ivanović N, Mariĉić1 A, et al. Hydrothermal Treatment of Electrochemically Synthesised Nanocrystalline Magnetic Iron Oxide Powder. Sci Sinter 2007; 39: 85-91.
51. Borysiuk J, Grabias A, Szczytko J, Bystrzejewski M, Twardowski A, Lange H. Structure and magnetic properties of carbon encapsulated Fe nanoparticles obtained by arc plasma and combustion synthesis. Carbon 2008; 46: 1693-701.
52. Rangaraju RR, Raja KS, Panday A, Misra M. An investigation on room temperature synthesis of vertically oriented arrays of iron oxide nanotubes by anodization of iron. Electrochim Acta 2010; 55: 785-93.
53. Alvarez GS, Muhammed M, Zagorodni AA. Novel flowinjection synthesis of iron oxide nanoparticles with narrowsize distribution. Chem Eng Sci 2006; 61: 4625-33.
54. Salazar-Alvarez G, Muhammed M, Zagorodni AA. Novel flow injection synthesis of iron oxide nanoparticles with narrow size distribution. Chem Eng Sci 2006; 61: 4625-33.
55. Shafi KVPM, Gedanken A, Goldfarb RB, Felner I. Sonochemical preparation of nanosized amorphous Fe-Ni alloys. J Appl Phys 1997; 81: 6901-5.
56. 4 Particles. J Phys Chem B 1997; 101: 6409-14.
57. 4 nanoparticles. J Colloid Interface Sci 2005; 284: 489-94.
58. Mizukoshi Y, Shuto T, Masahashi N, Tanabe S. Preparation of superparamagnetic magnetite nanoparticles by reverse precipitation method: contribution of sonochemically generated oxidants. Ultrason Sonochem 2009; 16: 525-31.
59. Pinkas J, Reichlova V, Serafimidisova A, Moravec Z, Zboril R, Jancik D, et al. Sonochemical Synthesis of Amorphous Yttrium Iron Oxides Embedded in Acetate Matrix and their Controlled Thermal Crystallization toward Garnet (Y3Fe5O12) and Perovskite (YFeO3) Nanostructures. J Phys Chem C 2010; 114: 13557-64.
60. Pinkas J, Reichlova V, Zboril R, Moravec Z, Bezdicka P, Matejkova J. Sonochemical synthesis of amorphous nanoscopic iron(III) oxide from Fe(acac)(3). Ultrason Sonochem 2008; 15: 257-64.
61. Viau G, Fiévet-Vincent F, Fiévet F. Monodisperse iron-based particles: precipitation in liquid polyols. J Mater Chem 1996; 6: 1047-53.
62. 4 pigment particles-synthesis and preparation of coatings. J Mater Chem 2000; 10: 1311-4.
63. 3 particles: Preparation and application. J Mater Res 2000; 15: 2244-8.
64. Joseyphus RJ, Kodama D, Matsumoto T, Sato Y, Jeyadevan B, Tohji K. Role of polyol in the synthesis of Fe particles. J Magn Magn Mater 2007; 310: 2393-5.
65. Cai W, Wan J. Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols. J Colloid Interface Sci 2007; 305: 366-70.
66. Carroll KJ, Shultz MD, Fatouros PP, Carpenter EE. High magnetization aqueous ferrofluid: A simple one-pot synthesis. J Appl Phys 2010; 107: 09B304.
67. Huang H, Xie QP, Kang MX, et al. Labeling transplanted mice islet with polyvinylpyrrolidone coated superparamagnetic iron oxide nanoparticles for in vivo detection by magnetic resonance imaging. Nanotechnology 2009; 20: 405102.
68. Xu FH, Cheng CM, Xu FJ, et al. Superparamagnetic magnetite nanocrystal clusters: a sensitive tool for MR cellular imaging. Nanotechnology 2009; 20: 405102.
69. 3 nanoparticles by highenergy ball milling. Physica B 2007; 390: 23-7.
70. Arbain R, Othman M, Palaniandy S. Preparation of iron oxide nanoparticles by mechanical milling. Miner Eng 2011; 24: 1-9.
71. Pourghahramani P, Altin E, Mallembakam MR, Peukert W, Forssberg E. Microstructural characterization of hematite during wet and dry millings using Rietveld and XRD line profile analyses. Powder Technol 2008; 186: 9-21.
72. Can MM, Ozcan S, Ceylan A, Firat T. Effect of milling time on the synthesis of magnetite nanoparticles by wet milling. Mate Sci Eng B-Adv Funct Solid-State Mater 2010; 172: 72-5.
73. Zhang Q, Kano, J., Saito, F. Fine grinding of material in dry systems and mechanochemistry. Handbook Powder Technol 2007; 12: 509-28.
74. Garcia F, Boley NL, Trompette JL, Frances C. On fragmentation and agglomeration phenomena in ultrafine wet grinding process: the role of polyelectrolyte additives. Int J Miner Process 2004; 74S: S43-54.
75. Randrianantoandro N, Mercier AM, Hervieu M, Greneche JM. Direct phase transformation from hematite to maghemite during high energy ball milling. Mater Lett 2001; 47: 150-8.
76. Uehara Y. Structural changes of iron oxides by ball-milling in different media. Bull Chem Soc Jpn 1975; 48: 3383-4.
77. 3 by grinding. J Mater Sci Lett 1996; 15: 461-2.
78. 3 nanoparticle during high energy ball milling. Scr Mater 2001; 44: 2023-6.
79. 3-doped calcium phosphates obtained by the mechanical milling method. Physica Scripta 2009; 79: 055601.
80. 3 nanoparticles prepared by flame pyrolysis of ferrocene in ethanol. J Nanosci Nanotechnol 2006; 6: 2155-8.
81. Buyukhatipoglu K, Miller TA, Clyne AM. Flame synthesis and in vitro biocompatibility assessment of superparamagnetic iron oxide nanoparticles: cellular uptake, toxicity and proliferation studies. J Nanosci Nanotechnol 2009; 9: 6834-43.
82. Kumfer BM, Shinoda K, Jeyadevan B, Kennedy IM. Gas-Phase Flame Synthesis and Properties of Magnetic Iron Oxide Nanoparticles with Reduced Oxidation State. J Aerosol Sci 2010; 41: 257-65.
83. 4 nanoparticles: effect of flame configuration, flame temperature, and additive loading. J Nanopart Res 2010; 12: 1495-508.
84. Pati RK, Lee IC, Hou S, et al. Flame synthesis of nanosized Cu-Ce- O, Ni-Ce-O, and Fe-Ce-O catalysts for the water-gas shift (WGS) reaction. ACS Appl Mater Interfaces 2009; 1: 2624-35.
85. Strobel R, Pratsinis SE. Direct synthesis of maghemite, magnetite and wustite nanoparticles by flame spray pyrolysis. Adv Powder Technol 2009; 20: 190-4.
86. Li D, Teoh WY, Selomulya C, Woodward RC, Amal R, Rosche B. Flame-sprayed superparamagnetic bare and silica-coated maghemite nanoparticles: Synthesis, characterization, and protein adsorption-desorption. Chem Mater 2006; 18: 6403-13.
87. 3 Nanoflake and CuO Nanoneedle Arrays. Nano Lett 2009; 9: 3001-6.
88. Guo B, Kennedy IM. Gas-phase flame synthesis and characterization of iron oxide nanoparticles for use in a health effects study. Aerosol Sci Technol 2007; 41: 944-51.
89. Mollah S, Henley SJ, Giusca CE, Silva SRP. Photo-Chemical Synthesis of Iron Oxide Nanowires Induced by Pulsed Laser Ablation of Iron Powder in Liquid Media. Integr Ferroelectr 2010; 119: 45-54.
90. Hong J, Xu DM, Yu JH, Gong PJ, Ma HJ, Yao SD. Facile synthesis of polymer-enveloped ultrasmall superparamagnetic iron oxide for magnetic resonance imaging. Nanotechnology 2007; 18: 135608.
91. 4-chitosan nanoparticles under UV irradiation in aqueous system. Curr Appl Phys 2010; 10: 828-33.
92. Lu AH, Salabas EL, Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 2007; 46: 1222-44.
93. Vincent BE, J, Emment, S, Jones, A. Colloids Surf B Biointerface 1986; 18: 261.
94. Cornell RM, Schertmann, U., ed. Iron Oxides in the Laboratory: Preparation and Characterization. 1991: Weinheim, Germany.
95. Napper DH. Flocculation studies of sterically stabilized dispersions. J Colloid Interface Sci 1970; 32: 106-14.
96. Fritz GS, V, Willenbacher, N, Wagner, N. J. Electrosteric stabilization of colloidal dispersions. Langmuir 2002; 18: 6381-90.
97. Ortega-Vinuesa JL, Martiacuten R, guez A, Hidalgo, et al. Colloidal Stability of Polymer Colloids with Different Interfacial Properties: Mechanisms. J Colloid Interface Sci 1996; 184: 259-67.
98. Kobayashi M, Skarba M, Galletto P, Cakara D, Borkovec M. Effects of heat treatment on the aggregation and charging of Stober-type silica. J Colloid Interface Sci 2005; 292: 139-47.
99. Cornell RMS, U., ed. The Iron Oxides: Structure, Properties, Reactions, Occurrence and Uses. 1996: Weinheim, Germany.
100. Sahoo YPH, Fried T, Golodnitsky D, Burstein L, Sukenik CN, Markovich G. Alkyl phosphonate/phosphate coating on magnetite nanoparticles: A comparison with fatty acids. Langmuir 2001; 17: 7907-11.
101. Sahoo Y, Goodarzi A, Swihart MT, et al. Aqueous ferrofluid of magnetite nanoparticles: Fluorescence labeling and magnetophoretic control. J Phys Chem B 2005; 109: 3879-85.
102. Hyeon T, Lee SS, Park J, Chung Y, Bin Na H. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc 2001; 123: 12798-801.
103. Wang CY, Hong JM, Chen G, Zhang Y, Gu N. Facile method to synthesize oleic acid-capped magnetite nanoparticles. Chinese Chem Lett 2010; 21: 179-82.
104. Ingram DR, Kotsmar C, Yoon KY, et al. Superparamagnetic nanoclusters coated with oleic acid bilayers for stabilization of emulsions of water and oil at low concentration. J Colloid Interface Sci 2010; 351: 225-32.
105. Regmi R, Black C, Sudakar C, et al. Effects of fatty acid surfactants on the magnetic and magnetohydrodynamic properties of ferrofluids. J Appl Phys 2009; 106:113902.
106. Wagner S, Schnorr J, Pilgrimm H, Hamm B, Taupitz M. Monomercoated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest Radiol 2002; 37: 167-77.
107. Taupitz M, Wagner S, Schnorr J, et al. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest Radiol 2004; 39: 394-405.
108. Tombach B, Reimer P, Mahler M. First-pass and equilibrium phase MRA following intravenous bolus injection of SH U 555 C: phase I clinical trial in elderly volunteers with risk factors for arterial vascular disease. Acad Radiol 2002; 9(Suppl 2): S425-7.
109. McLachlan SJ, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 1994; 4: 301-7.
110. Shen T, Weissleder R, Papisov M, Bogdanov A, Jr., Brady TJ. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 1993; 29: 599-604.
111. Liu CH, PM. Atomic force microscopy and surface characteristics of iron oxides formed in citrate solutions. Soil Sci Soc Am J 1999; 63: 65-72.
112. Fauconnier NBA, Roger J, Pons JN. Adsorption of gluconic and citric acids on maghemite particles in aqueous medium. Prog Colloid Polym Sci 1996; 100: 212-6.
113. Fauconnier N, Pons JN, Roger J, Bee A. Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid. J Colloid Interface Sci 1997; 194: 427-33.
114. Denizot B, Tanguy G, Hindre F, Rump E, Jacques Le Jeune J, Jallet P. Phosphorylcholine Coating of Iron Oxide Nanoparticles. J Colloid Interface Sci 1999; 209: 66-71.
115. Portet D, Denizot B, Rump E, Lejeune JJ, Jallet P. Nonpolymeric Coatings of Iron Oxide Colloids for Biological Use as Magnetic Resonance Imaging Contrast Agents. J Colloid Interface Sci 2001; 238: 37-42.
116. Fauconnier NBA, Roger J, Pons JN. Synthesis of aqueous magnetic liquids by surface complexation of maghemite nanoparticles. J Mol Liq 1999; 83: 233-242.
117. Kodama H, Schnitzer, M. Effect of fulvic acid on the crystallization of Fe(III) oxides. Geoderma 1977; 19: 279-91.
118. Kandori K, Kawashima Y, Ishikawa T. Effects of citrate ions on the formation of monodispersed cubic hematite particles J Colloid Interface Sci 1992; 152: 284-8.
119. Kandori K, Kawashima Y, Ishikawa T. Effects of citrate ions on the formation of ferric oxide hydroxide particles. J Mater Sci 1991; 26: 3313-9.
120. Portet DDB, Rump E, Hindre F, LeJeune JJ, Jallet P. Comparative biodistribution of thin-coated iron oxide nanoparticles TCION: Effect of different bisphosphonate coatings. Drug Dev Res 2001; 54: 173-81.
121. Mutin PHGG, Vioux A. Organic-inorganic hybrid materials based on organophosphorus coupling molecules: from metal phosphonates to surface modification of oxides. C R Chim 2003; 6: 1153-64.
122. Kreller DIGG, Novak W, Van Loon GW, Hugh Horton J. Competitive adsorption of phosphate and carboxylate with natural organic matter on hydrous iron oxides as investigated by chemical force microscopy. Colloids Surf, A 2003; 212: 249-64.
123. Wilhelm C, Gazeau F, Roger J, Pons JN, Bacri JC. Interaction of anionic superparamagnetic nanoparticles with cells: Kinetic analyses of membrane adsorption and subsequent internalization. Langmuir 2002; 18: 8148-55.
124. Wilhelm C, Gazeau F, Bacri JC. Magnetophoresis and ferromagnetic resonance of magnetically labeled cells. European Biophysics J Biophys Lett 2002; 31: 118-25.
125. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003; 24: 1001-11.
126. Wilhelm C, Gazeau F. Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 2008; 29: 3161-74.
127. Hafeli U, Schutt W, Teller J, Zbrorowski M. Scientific and Clinical Applications of Magnetic Carriers. 1997, New York.
128. Arshady R, Radiolabeled and Magnetic Particles in Medicine and Biology. Vol. 3. 2001, London, U.K.
129. Okassa LN, Marchais H, Douziech-Eyrolles L, et al. Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles. Int J Pharm 2005; 302: 187-96.
130. Zhang Y, Kohler N, Zhang MQ. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002; 23: 1553-61.
131. Lacava LM, Lacava ZGM, Da Silva MF, et al. Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. Biophys J 2001; 80: 2483-6.
132. Berry CC, Wells S, Charles S, Curtis AS. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003; 24: 4551-7.
133. Gamarra LF, Brito GES, Pontuschka WM, Amaro E, Parma AHC, Goya GF. Biocompatible superparamagnetic iron oxide nanoparticles used for contrast agents: a structural and magnetic study. J Magn Magn Mater 2005; 289: 439-41.
134. Ding J, Tao K, Li JY, Song S, Sun K. Cell-specific cytotoxicity of dextran-stabilized magnetite nanoparticles. Colloid Surf BBiointerface 2010; 79: 184-90.
135. Paul KG, Frigo TB, Groman JY, Groman EV. Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. Bioconjug Chem 2004; 15: 394-401.
136. Pardoe H, Chua-anusorn W, St Pierre TG, Dobson J. Structural and magnetic properties of nanoscale iron oxide particles synthesized in the presence of dextran or polyvinyl alcohol. J Magn Magn Mater 2001; 225: 41-6.
137. Cabuil V. Phase behavior of magnetic nanoparticles dispersions in bulk and confined geometries. Curr Opin Colloid Interface Sci 2000; 5: 44-8.
138. Bautista MC, Bomati-Miguel O, Morales MD, Serna CJ, Veintemillas-Verdaguer S. Surface characterisation of dextrancoated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitation. J Magn Magn Mater 2005; 293: 20-7.
139. Jiang JS, Gan ZF, Yang Y, Du B, Qian M, Zhang P. A novel magnetic fluid based on starch-coated magnetite nanoparticles functionalized with homing peptide. J Nanopart Res 2009; 11: 1321-30.
140. Dung TT, Danh TM, Hoa LTM, Chien DM, Duc NH. Structural and magnetic properties of starch-coated magnetite nanoparticles. J Exp Nanosci 2009; 4: 259-67.
141. Shultz MD, Calvin S, Fatouros PP, Morrison SA, Carpenter EE. Enhanced ferrite nanoparticles as MRI contrast agents. J Magn Magn Mater 2007; 311: 464-8.
142. Butterworth MD, Illum L, Davis SS. Preparation of ultrafine silicaand PEG-coated magnetite particles. Colloids and Surfaces a- Physicochem Eng Aspects 2001; 179: 93-102.
143. Yallapu MM, Foy SP, Jain TK, Labhasetwar V. PEGFunctionalized Magnetic Nanoparticles for Drug Delivery and Magnetic Resonance Imaging Applications. Pharm Res 2010; 27: 2283-95.
144. Liu SJ, Han YC, Qiao RR, et al. Investigations on the Interactions between Plasma Proteins and Magnetic Iron Oxide Nanoparticles with Different Surface Modifications. J Phys Chem C 2010; 114: 21270-6.
145. Gupta AK, Curtis ASG. Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture. J Mater Sci-Mater Med 2004; 15: 493-6.
146. 4@SiO2 Nanoparticles via Bioinspired Silification for Magnetic Resonance Imaging. Adv Funct Mater 2010; 20: 722-31.
147. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine (Lond) 2007; 2: 23-39.
148. Xue B, Sun Y. Protein adsorption equilibria and kinetics to a poly(vinyl alcohol)-based magnetic affinity support. J Chromatogr A 2001; 921: 109-19.
149. Chastellain M, Petri A, Hofmann H. Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. J Colloid Interface Sci 2004; 278: 353-60.
150. 4 particles by precipitation in the presence of PVA at high pH. J Colloid Interface Sci 1996; 177: 490-4.
151. Maruoka S, Matsuura T, Kawasaki K, et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res 2006; 31: 599-606.
152. Mohapatra S, Pramanik N, Ghosh SK, Pramanik P. Synthesis and characterization of ultrafine poly(vinylalcohol phosphate) coated magnetite nanoparticles. J Nanosci Nanotechnol 2006; 6: 823-9.
153. Liao MH, Chen DH. Preparation and characterization of a novel magnetic nano-adsorbent. J Mater Chem 2002; 12: 3654-9.
154. Mak SY, Chen DH. Fast adsorption of methylene blue on polyacrylic acid-bound iron oxide magnetic nanoparticles. Dyes and Pigments 2004; 61: 93-8.
155. Mak SY, Chen DH. Binding and sulfonation of poly(acrylic acid) on iron oxide nanoparticles: a novel, magnetic, strong acid cation nano-adsorbent. Macromolecular Rapid Commun 2005; 26: 1567-71.
156. Wu Y, Guo J, Yang WL, Wang CC, Fu SK. Preparation and characterization of chitosan-poly(acrylic acid) polymer magnetic microspheres. Polymer 2006; 47: 5287-94.
157. Lim S, Yang D, Lee SW. Fabrication of Magnetite-Hydrogel Nanocomposites with Clustered Magnetite Cores and Poly(Nisopropylacrylamide- co-acrylic acid) Shells for Drug Delivery Application. J Nanosci Nanotech 2010; 10: 7295-9.
158. Zhang F, Wang CC. Preparation of P(NIPAM-co-AA) Microcontainers Surface-Anchored with Magnetic Nanoparticles. Langmuir 2009; 25: 8255-62.
159. Kopke RD, Wassel RA, Mondalek F, et al. Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant. Audiol Neurootol 2006; 11: 123-33.
160. Gomez-Lopera SA, Plaza RC, Delgado AV. Synthesis and Characterization of Spherical Magnetite/Biodegradable Polymer Composite Particles. J Colloid Interface Sci 2001; 240: 40-7.
161. 3 in iron(II) cross-linked alginate gels. Chem Mater 1996; 8: 1594-6.
162. Llanes F, Ryan DH, Marchessault RH. Magnetic nanostructured composites using alginates of different M/G ratios as polymeric matrix. Int J Biol Macromol 2000; 27: 35-40.
163. Nishio Y, Yamada A, Ezaki K, Miyashita Y, Furukawa H, Horie K. Preparation and magnetometric characterization of iron oxidecontaining alginate/poly(vinyl alcohol) networks. Polymer 2004; 45: 7129-36.
164. Ma HL, Qi XR, Maitani Y, Nagai T. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm 2007; 333: 177-86.
165. 4 magnetic nanoparticles. Nanotechnology 2010; 21: 445601.
166. Roque ACA, Bicho A, Batalha IL, Cardoso AS, Hussain A. Biocompatible and bioactive gum Arabic coated iron oxide magnetic nanoparticles. J Biotechnol 2009; 144: 313-20.
167. Sipos P, Berkesi O, Tombacz E, St Pierre TG, Webb J. Formation of spherical iron(III) oxyhydroxide nanoparticles sterically stabilized by chitosan in aqueous solutions. J Inorg Biochem 2003; 95: 55-63.
168. Kim EH, Lee HS, Kwak BK, Kim BK. Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent. J Magn Magn Mater 2005; 289: 328-30.
169. Lee HS, Kim EH, Shao HP, Kwak BK. Synthesis of SPIO-chitosan microspheres for MRI-detectable embolotherapy. J Magn Magn Mater 2005; 293: 102-5.
170. Chaleawlert-umpon S, Mayen V, Manotham K, Pimpha N. Preparation of Iron Oxide-Entrapped Chitosan Nanoparticles for Stem Cell Labeling. J Biomater Sci-Polym Ed 2010; 21: 1515-32.
171. 4- chitosan nanoparticles used for hyperthermia. Adv Powder Technol 2010; 21: 461-7.
172. Brus C, Petersen H, Aigner A, Czubayko F, Kissel T. Physicochemical and biological characterization of polyethylenimine- graft-poly(ethylene glycol) block copolymers as a delivery system for oligonucleotides and ribozymes. Bioconjugate Chem 2004; 15: 677-84.
173. Chiang CL, Sung CS. Purification of transfection-grade plasmid DNA from bacterial cells with superparamagnetic nanoparticles. J Magn Magn Mater 2006; 302: 7-13.
174. Aanton M, Plank C, Rojo E. 7th meeting of the European Society of Gene Therapy. November 26-28 1999, Munich, Germany. J Gene Med 2000; 2: 66-70.
175. Huth S, Lausier J, Gersting SW, et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 2004; 6: 923-36.
176. Buerli T, Pellegrino C, Baer K, et al. Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat Protoc 2007; 2: 3090-101.
177. Shi Y, Zhou L, Wang R, et al. In situ preparation of magnetic nonviral gene vectors and magnetofection in vitro. Nanotechnology 2010; 21: 115103.
178. Pickard M, Chari D. Enhancement of magnetic nanoparticlemediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields. Nanomedicine (Lond) 2010; 5: 217-32.
179. Mykhaylyk O, Zelphati O, Rosenecker J, Plank C. siRNA delivery by magnetofection. Curr Opin Mol Ther 2008; 10: 493-505.
180. Namgung R, Singha K, Yu MK, et al. Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells. Biomaterials 2010; 31: 4204-13.
181. Chertok B, David AE, Yang VC. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials 2010; 31: 6317-24.
182. Ramanujan RV, Ang KL, Venkatraman S. Magnet-PNIPA hydrogels for bioengineering applications. Journal of Materials Science 2009; 44: 1381-7.
183. Purushotham S, Chang PEJ, Rumpel H, et al. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy. Nanotechnology 2009; 20: 305101.
184. Meenach SA, Anderson AA, Suthar M, Anderson KW, Hilt JZ. Biocompatibility analysis of magnetic hydrogel nanocomposites based on poly(N-isopropylacrylamide) and iron oxide. Journal of Biomedical Materials Research Part A 2009; 91A: 903-9.
185. 4 Nanoparticles via Surface- Initiated RAFT Copolymerization of N-Isopropylacrylamide and Acrolein. J Polym Sci A-Polym Chem 2010; 48: 542-50.
186. Brazel CS. Magnetothermally-responsive Nanomaterials: Combining Magnetic Nanostructures and Thermally-Sensitive Polymers for Triggered Drug
187. Zhang J, Misra RDK. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core-shell nanoparticle carrier and drug release response. Acta Biomaterialia 2007; 3: 838-50.
188. Narain R, Gonzales M, Hoffman AS, Stayton PS, Krishnan KM. Synthesis of monodisperse biotinylated p(NIPAAm)-coated iron oxide magnetic nanoparticles and their bioconjugation to streptavidin. Langmuir 2007; 23: 6299-304.
189. 4 nanoparticles as a MRI contrast agent. J Mater Sci-Mater Med 2010; 21: 1205-10.
190. 4 nanoparticles for colorimetric sensing of glucose and selective extraction of thiol. Biosensors Bioelectron 2010; 26: 913-7.
191. Utech S, Scherer C, Krohne K, et al. Magnetic polyorganosiloxane core-shell nanoparticles: Synthesis, characterization and magnetic fractionation. J Magn Magn Mater 2010; 322: 3519-26.
192. Zhang XJ, Jiang W, Li FS, Sun ZD, Ou'yang Z. Controllable preparation of magnetic polymer nanospheres with high saturation magnetization by miniemulsion polymerization. Mater Lett 2010; 64: 119-21.
193. 4 Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent: An In Vitro Assessment. Adv Funct Mater 2009; 19: 2615-22.
194. Daniel MC, Astruc D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 2004; 104: 293-346.
195. Eustis S, El-Sayed MA. Why gold nanoparticles are more precious than pretty gold: Noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem Soc Rev 2006; 35: 209-17.
196. Shubayev VI, Pisanic TR, Jin SH. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 2009; 61: 467-77.
197. 4-Au nanoparticle for biomolecule immobilization and detection. J Nanopart Res 2010; 12: 1187-96.
198. Lyon JL, Fleming DA, Stone MB, Schiffer P, Williams ME. Synthesis of Fe oxide core/Au shell nanoparticles by iterative hydroxylamine seeding. Nano Lett 2004; 4: 719-23.
199. Kojima H, Mukai Y, Yoshikawa M, et al. Simple PEG Conjugation of SPIO via an Au-S Bond Improves Its Tumor Targeting Potency as a Novel MR Tumor Imaging Agent. Bioconjugate Chem 2010; 21: 1026-31.
200. Kumagai M, Sarma TK, Cabral H, et al. Enhanced in vivo Magnetic Resonance Imaging of Tumors by PEGylated Iron- Oxide-Gold Core-Shell Nanoparticles with Prolonged Blood Circulation Properties. Macromol Rapid Commun 2010; 31: 1521-8.
201. Sun L, Zhang CZ, Chen LG, et al. Preparation of alumina-coated magnetite nanoparticle for extraction of trimethoprim from environmental water samples based on mixed hemimicelles solidphase extraction. Anal Chim Acta 2009; 638: 162-8.
202. Lesnikovich AES, TM, Naumenko VN, Vorobyova SA, Baykov MW. Dispersity of magnetite in magnetic liquids and the interaction with a surfactant J Magn Magn Mater 1990; 85: 14-6.
203. Vogt C, Toprak MS, Muhammed M, Laurent S, Bridot JL, Muller RN. High quality and tuneable silica shell-magnetic core nanoparticles. J Nanopart Res 2010; 12: 1137-47.
204. Sun YK, Duan L, Guo ZR, et al. An improved way to prepare superparamagnetic magnetite-silica core-shell nanoparticles for possible biological application. J Magn Magn Mater 2005; 285: 65-70.
205. Ulman A. Formation and structure of self-assembled monolayers. Chem Rev 1996; 96: 1533-54.
206. Lu Y, Yin YD, Li ZY, Xia YA. Synthesis and self-assembly of Au@SiO2 core-shell colloids. Nano Lett 2002; 2: 785-8.
207. Deng YH, Wang CC, Hu JH, Yang WL, Fu SK. Investigation of formation of silica-coated magnetite nanoparticles via sol-gel approach. Colloid Surf A-Physicochem Eng Asp 2005; 262: 87-93.
208. Barnakov YA, Yu MH, Rosenzweig Z. Manipulation of the magnetic properties of magnetite-silica nanocomposite materials by controlled Stober synthesis. Langmuir 2005; 21: 7524-7.
209. Im SH, Herricks T, Lee YT, Xia YN. Synthesis and characterization of monodisperse silica colloids loaded with superparamagnetic iron oxide nanoparticles. Chem Phys Lett 2005; 401: 19-23.
210. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007; 2: 23-39.
211. Hahn PF, Stark DD, Lewis JM, et al. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 1990; 175: 695-700.
212. Lo CY, Chen WY, Chen CT, Chen YC. Rapid enrichment of phosphopeptides from tryptic digests of proteins using iron oxide nanocomposites of magnetic particles coated with zirconia as the concentrating probes. J Proteome Res 2007; 6: 887-93.
213. Chen CT, Chen WY, Tsai PJ, Chien KY, Yu JS, Chen YC. Rapid enrichment of phosphopeptides and phosphoproteins from complex samples using magnetic particles coated with alumina as the concentrating probes for MALDI MS analysis. J Proteome Res 2007; 6: 316-25.
214. Yamanaka S, Uno M. Synthesis and Application of Titanium Oxide Nanohole Arrays. Inorganic and Metallic Nanotubular Materials: Recent Technol Appl 2010; 117: 59-71.
215. 4 @ TiO2 magnetic nanoparticles in the selective enrichment of phosphopeptides from human serum. J Biomed Nanotechnol 2008; 4: 73-9.
216. Wiogo HTR, Lim M, Bulmus V, Yun J, Amal R. Stabilization of Magnetic Iron Oxide Nanoparticles in Biological Media by Fetal Bovine Serum (FBS). Langmuir 2011; 27: 843-50.
217. Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol 2010; 624: 25-37.
218. Solaro R. Targeted Delivery of Proteins by Nanosized Carriers. J Polym Sci A-Polym Chem 2008; 46: 1-11.
219. Park JH, Lee S, Kim J-H, Park K, Kim K, Kwon IC. Polymeric nanomedicine for cancer therapy. Prog Polym Sci 2008; 33: 113-37.
220. Cerdan S, Lotscher HR, Kunnecke B, Seelig J. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magn Reson Med 1989; 12: 151-63.
221. Ibraimi F, Kriz D, Lu M, Hansson LO, Kriz K. Rapid one-step whole blood C-reactive protein magnetic permeability immunoassay with monoclonal antibody conjugated nanoparticles as superparamagnetic labels and enhanced sedimentation. Anal Bioanal Chem 2006; 384: 651-7.
222. Remsen LG, McCormick CI, Roman-Goldstein S, et al. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. AJNR Am J Neuroradiol 1996; 17: 411-8.
223. Bulte JW, Hoekstra Y, Kamman RL, et al. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextranmagnetite particles. Magn Reson Med 1992; 25: 148-57.
224. Chen TJ, Cheng TH, Chen CY, et al. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. J Biol Inorg Chem 2009; 14: 253-60.
225. Cheng CM, Chu PY, Chuang KH, et al. Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems. Cancer Gene Ther 2009; 16: 83-90.
226. Huang G, Zhang CF, Li SZ, et al. A novel strategy for surface modification of superparamagnetic iron oxide nanoparticles for lung cancer imaging. J Mater Chem 2009; 19: 6367-72.
227. Chang J, Jallouli Y, Kroubi M, et al. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. Int J Pharm 2009; 379: 285-92.
228. Zhang CY, Lu J, Tsourkas A. Iron chelator-based amplification strategy for improved targeting of transferrin receptor with SPIO. Cancer Biol Ther 2008; 7: 889-95.
229. Huang RQ, Qu YH, Ke WL, Zhu JH, Pei YY, Jiang C. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J 2007; 21: 1117-25.
230. Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim Et Biophys Acta-Mol Cell Res 1998; 1402: 239-49.
231. Weissleder R, Moore A, Mahmood U, et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000; 6: 351-5.
232. Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta 1998; 1402: 239-49.
233. Robert L. Interaction between cells and elastin, the elastin-receptor. Connective Tissue Res 1999; 40: 75-82.
234. Berry CC, Rudershausen S, Teller J, Curtis AS. The influence of elastin-coated 520-nm- and 20-nm-diameter nanoparticles on human fibroblasts in vitro. IEEE Trans Nanobiosci 2002; 1: 105-9.
235. Bhadriraju K, Hansen LK. Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins. Biomaterials 2000; 21: 267-72.
236. Rerat V, Laurent S, Burtea C, et al. Ultrasmall particle of iron oxide--RGD peptidomimetic conjugate: synthesis and characterisation. Bioorg Med Chem Lett 2010; 20: 1861-5.
237. Temming K, Schiffelers RM, Molema G, Kok RJ. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist Updat 2005; 8: 381-402.
238. Montet X, Montet-Abou K, Reynolds F, Weissleder R, Josephson L. Nanoparticle imaging of integrins on tumor cells. Neoplasia 2006; 8: 214-22.
239. Veiseh O, Sun C, Fang C, et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 2009; 69: 6200-7.
240. Veiseh O, Gunn JW, Kievit FM, et al. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 2009; 5: 256-64.
241. Chen AM, Zhang M, Wei D, et al. Co-delivery of Doxorubicin and Bcl-2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug-Resistant Cancer Cells. Small 2009; 5: 2673-7.
242. Sun C, Veiseh O, Gunn J, et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008; 4: 372-9.
243. Kohler N, Sun C, Fichtenholtz A, Gunn J, Fang C, Zhang MQ. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2006; 2: 785-92.
244. Zhou J, Leuschner C, Kumar C, Hormes JF, Soboyejo WO. Subcellular accumulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials 2006; 27: 2001-8.
245. Leuschner C, Kumar CS, Hansel W, Soboyejo W, Zhou J, Hormes J. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Breast Cancer Res Treat 2006; 99: 163-76.
246. Sega EI, Low PS. Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev 2008; 27: 655-64.
247. Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2008; 41: 120-9.
248. Leamon CP. Folate-targeted drug strategies for the treatment of cancer. Curr Opin Investig Drugs 2008; 9: 1277-86.
249. Hilgenbrink AR, Low PS. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci 2005; 94: 2135-46.
250. Yoo HS, Park TG. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release 2004; 100: 247-56.
251. de Oliveira HC, Fonseca JL, Pereira MR. Chitosan-poly(acrylic acid) polyelectrolyte complex membranes: preparation, characterization and permeability studies. J Biomater Sci Polym Ed 2008; 19: 143-60.
252. Sun C, Sze R, Zhang M. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A 2006; 78: 550-7.
253. Ke JH, Lin JJ, Carey JR, Chen JS, Chen CY, Wang LF. A specific tumor-targeting magnetofluorescent nanoprobe for dual-modality molecular imaging. Biomaterials 2010; 31: 1707-15.
254. Lin JJ, Chen JS, Huang SJ, et al. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials 2009; 30: 5114-24.
255. Yang X, Grailer JJ, Rowland IJ, et al. Multifunctional SPIO/DOXloaded wormlike polymer vesicles for cancer therapy and MR imaging. Biomaterials 2010; 31: 9065-73.
256. Dobson J. Magnetic nanoparticles for drug delivery. Drug Devel Res 2006; 67: 55-60.
257. Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003; 36: R167-R81.
258. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv Drug Deli Rev 2011; 63: 24-46.
259. Gupta AK, Berry C, Gupta M, Curtis A. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans Nanobiosci 2003; 2: 255-61.
260. Hu SH, Chen SY, Liu DM, Hsiao CS. Core/single-crystal-shell nanospheres for controlled drug release via a magnetically triggered rupturing mechanism. Adv Mater 2008; 20: 2690-5.
261. Liu TY, Hu SH, Liu KH, Shaiu RS, Liu DM, Chen SY. Instantaneous Drug Delivery of Magnetic/Thermally Sensitive Nanospheres by a High-Frequency Magnetic Field. Langmuir 2008; 24: 13306-11.
262. Hu SH, Tsai CH, Liao CF, Liu DM, Chen SY. Controlled Rupture of Magnetic Polyelectrolyte Microcapsules for Drug Delivery. Langmuir 2008; 24: 11811-8.
263. Alexiou C, Schmidt A, Klein R, Hulin P, Bergemann C, Arnold W. Magnetic drug targeting: biodistribution and dependency on magnetic field strength. J Magn Magn Mater 2002; 252: 363-6.
264. Lubbe AS, Bergemann C, Brock J, McClure DG. Physiological aspects in magnetic drug-targeting. J Magn Magn Mater 1999; 194: 149-55.
265. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007; 2: 23-39.
266. Sun XC, Gutierrez A, Yacaman MJ, Dong XL, Jin S. Investigations on magnetic properties and structure for carbon encapsulated nanoparticles of Fe, Co, Ni. Mater Sci Eng A-Struc Mater Prop Microstru Proc 2000; 286: 157-60.
267. Gonzales M, Krishnan KM. Synthesis of magnetoliposomes with monodisperse iron oxide nanocrystal cores for hyperthermia. J Magn Magn Mater 2005; 293: 265-70.
268. Steinfeld U, Pauli C, Kaltz N, Bergemann C, Lee HH. T lymphocytes as potential therapeutic drug carrier for cancer treatment. Int J Pharm 2006; 311: 229-36.
269. Sun C, Sze R, Zhang MQ. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A 2006; 78A: 550-7.
270. Garinot M, Fievez V, Pourcelle V, et al. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release 2007; 120: 195-204.
271. Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008; 130: 98-106.
272. Jain TK, Foy SP, Erokwu B, Dimitrijevic S, Flask CA, Labhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials 2009; 30: 6748-56.
273. Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008; 29: 4012-21.
274. Lee PW, Hsu SH, Wang JJ, et al. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles. Biomaterials 2010; 31: 1316-24.
275. Butoescu N, Seemayer CA, Foti M, Jordan O, Doelker E. Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials 2009; 30: 1772-80.
276. Butoescu N, Jordan O, Burdet P, et al. Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: Physicochemical and magnetic properties, and in vitro and in vivo drug release. Eur J Pharm Biopharm 2009; 72: 529-38.
277. Okassa LN, Marchais H, Douziech-Eyrolles L, et al. Optimization of iron oxide nanoparticles encapsulation within poly(D,L-lactideco- glycolide) sub-micron particles. Eur J Pharm Biopharm 2007; 67: 31-8.
278. Chorny M, Polyak B, Alferiev IS, Walsh K, Friedman G, Levy RJ. Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles. FASEB J 2007; 21: 2510-9.
279. Yang F, Li Y, Chen Z, Zhang Y, Wu J, Gu N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 2009; 30: 3882-90.
280. Liu YT, Hu SH, Liu DM, Chen SY, Chen IW. Biomedical nanoparticle carriers with combined thermal and magnetic responses. Nano Today 2009; 4: 52-65.
281. Lai CY, Trewyn BG, Jeftinija DM, et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 2003; 125: 4451-9.
282. Zhang JL, Srivastava RS, Misra RDK. Core-shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: Synthesis, characterization, and LCST of viable drugtargeting delivery system. Langmuir 2007; 23: 6342-51.
283. Giri S, Trewyn BG, Stellmaker MP, Lin VSY. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Edit 2005; 44: 5038-44.
284. Kim GC, Li YY, Chu YF, Cheng SX, Zhang XZ, Zhuo RX. A nanosized, thermo-sensitive drug carrier: self-assembled Fe(3)O(4)-OA-g-P(OA-co-NIPAAm) magnetomicelles. J Biomater Sci Polym Ed 2008; 19: 1249-59.
285. Rahimi M, Meletis EI, You S, Nguyen K. Formulation and characterization of novel temperature sensitive polymer-coated magnetic nanoparticles. J Nanosci Nanotechnol 2010; 10: 6072-81.
286. Liu TY, Hu SH, Liu KH, Shaiu RS, Liu DM, Chen SY. Instantaneous Drug Delivery of Magnetic/Thermally Sensitive Nanospheres by a High-Frequency Magnetic Field. Langmuir 2008; 24: 13306-11.
287. Satturwar P, Eddine MN, Ravenelle F, Leroux JC. pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth) acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil. Eur J Pharm Biopharm 2007; 65: 379-87.
288. Lee J, Joo MK, Kim J, Park JS, Yoon MY, Jeong B. Temperaturesensitive biodegradable poly(ethylene glycol). J Biomater Sci Polym Ed 2009; 20: 957-65.
289. Ghosh S, Ghoshmitra S, Cai T, Diercks DR, Mills NC, Hynds DL. Alternating Magnetic Field Controlled, Multifunctional Nano- Reservoirs: Intracellular Uptake and Improved Biocompatibility. Nanoscale Res Lett 2009; 5: 195-204.
290. Daniel-da-Silva AL, Fateixa S, Guiomar AJ, et al. Biofunctionalized magnetic hydrogel nanospheres of magnetite and kappa-carrageenan. Nanotechnology 2009; 20: 355602.
291. Daniel-da-Silva AL, Trindade T, Goodfellow BJ, Costa BFO, Correia RN, Gil AM. In Situ Synthesis of Magnetite Nanoparticles in Carrageenan Gels. Nanotechnology 2007; 8: 2350-7.
292. Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978; 202: 1290-3.
293. Soenen SJ, Hodenius M, De Cuyper M. Magnetoliposomes: versatile innovative nanocolloids for use in biotechnology and biomedicine. Nanomedicine 2009; 4: 177-91.
294. Yatvin MB, Tegmo-Larsson IM, Dennis WH. Temperature- and pH-sensitive liposomes for drug targeting. Methods Enzymol 1987; 149: 77-87.
295. Pradhan P, Giri J, Rieken F, et al. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release 2010; 142: 108-21.
296. Grief AD, Richardson G. Mathematical modelling of magnetically targeted drug delivery. J Magn Magn Mater 2005; 293: 455-63.
297. Plank C, Schillinger U, Scherer F, et al. The magnetofection method: Using magnetic force to enhance gene delivery. Biol Chem 2003; 384: 737-47.
298. Nellen W, Lichtenstein C. What makes an mRNA anti-sense-itive? Trends Biochem Sci 1993; 18: 419-23.
299. Izant JG, Weintraub H. Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis. Cell 1984; 36: 1007-15.
300. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-11.
301. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-8.
302. Dorsett Y, Tuschl T. siRNAs: Applications in functional genomics and potential as therapeutics. Nature Rev Drug Discov 2004; 3: 318-29.
303. Mehier-Humbert S, Guy RH. Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv Drug Deliv Rev 2005; 57: 733-53.
304. Plank C, Anton M, Rudolph C, Rosenecker J, Krotz F. Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opin Biol Ther 2003; 3: 745-58.
305. Polyak B, Friedman G. Magnetic targeting for site-specific drug delivery: applications and clinical potential. Expert Opin Drug Deliv 2009; 6: 53-70.
306. Luo D, Saltzman WM. Enhancement of transfection by physical concentration of DNA at the cell surface. Nat Biotechnol 2000; 18: 893-5.
307. Huth S, Lausier J, Gersting SW, et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 2004; 6: 923-36.
308. Isalan M, Santori MI, Gonzalez C, Serrano L. Localized transfection on arrays of magnetic beads coated with PCR products. Nat Method 2005; 2: 113-8.
309. Mykhaylyk O, Vlaskou D, Tresilwised N, Pithayanukul P, Moller W, Plank C. Magnetic nanoparticle formulations for DNA and siRNA delivery. J Magn Magn Mater 2007; 311: 275-81.
310. Mykhaylyk O, Antequera YS, Vlaskou D, Plank C. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc 2007; 2: 2391-411.
311. Mykhaylyk O, Zelphati O, Hammerschmid E, Anton M, Rosenecker J, Plank C. Recent advances in magnetofection and its potential to deliver siRNAs in vitro. Methods Mol Biol 2009; 487: 111-46.
312. Plank C, Schillinger U, Scherer F, et al. The magnetofection method: using magnetic force to enhance gene delivery. Biol Chem 2003; 384: 737-47.
313. Bhattarai SR, Kim SY, Jang KY, et al. N-hexanoyl chitosanstabilized magnetic nanoparticles: enhancement of adenoviralmediated gene expression both in vitro and in vivo. Nanomedicine 2008; 4: 146-54.
314. Scherer F, Anton M, Schillinger U, et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 2002; 9: 102-9.
315. Boussif O, Lezoualch F, Zanta MA, et al. A Versatile Vector for Gene and Oligonucleotide Transfer into Cells in Culture and in- Vivo - Polyethylenimine. Proc Nat Acad Sci 1995; 92: 7297-301.
316. Moffatt S, Wiehle S, Cristiano RJ. A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy. Gene Ther 2006; 13: 1512-23.
317. Malek A, Merkel O, Fink L, Czubayko F, Kissel T, Aigner A. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes. Toxicol Appl Pharmacol 2009; 236: 97-108.
318. Merkel OM, Beyerle A, Librizzi D, et al. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance. Mol Pharm 2009; 6: 1246-60.
319. Yiu HHP, McBain SC, El Haj AJ, Dobson J. A triple-layer design for polyethyleneimine-coated, nanostructured magnetic particles and their use in DNA binding and transfection. Nanotechnology 2007; 18: 435601.
320. Dobson J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 2006; 13: 283-7.
321. Xiang L, Bin W, Huali J, et al. Bacterial magnetic particles (BMPs)-PEI as a novel and efficient non-viral gene delivery system. J Gene Med 2007; 9: 679-90.
322. Boe S, Longva AS, Hovig E. Evaluation of various polyethylenimine formulations for light-controlled gene silencing using small interfering RNA molecules. Oligonucleotides 2008; 18: 123-32.
323. Malek A, Czubayk F, Aigner A. PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNAinduced gene targeting efficacy. J Drug Target 2008; 16: 124-39.
324. Plank C, Rosenecker J. Magnetofection: the use of magnetic nanoparticles for nucleic acid delivery. CSH Protoc 2009; 2009: pdb prot5230.
325. Park JW, Bae KH, Kim C, Park TG. Clustered magnetite nanocrystals cross-linked with PEI for efficient siRNA delivery. Biomacromolecules 2011; 12: 457-65.
326. Veiseh O, Kievit FM, Fang C, et al. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. Biomaterials 2010; 31: 8032-42.
327. Veiseh O, Sun C, Gunn J, et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 2005; 5: 1003-8.
328. Chen GH, Chen WJ, Wu Z, et al. MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. Biomaterials 2009; 30: 1962-70.
329. Arsianti M, Lim M, Marquis CP, Amal R. Assembly of Polyethylenimine-Based Magnetic Iron Oxide Vectors: Insights into Gene Delivery. Langmuir 2010; 26: 7314-26.
330. Zhang Y, Liu JY, Yang F, et al. A new strategy for assembling multifunctional nanocomposites with iron oxide and aminoterminated PAMAM dendrimers. J Mater Sci-Mater Med 2009; 20: 2433-40.
331. Agrawal A, Min DH, Singh N, et al. Functional Delivery of siRNA in Mice Using Dendriworms. ACS Nano 2009; 3: 2495-504.
332. Lee JH, Lee K, Moon SH, Lee Y, Park TG, Cheon J. All-in-One Target-Cell-Specific Magnetic Nanoparticles for Simultaneous Molecular Imaging and siRNA Delivery. Angew Chem Int Edit 2009; 48: 4174-9.
333. Boyer C, Priyanto P, Davis TP, et al. Anti-fouling magnetic nanoparticles for siRNA delivery. J Mater Chem 2010; 20: 255-65.
334. Cai D, Mataraza JM, Qin ZH, et al. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat Method 2005; 2: 449-54.
335. Morishita N, Nakagami H, Morishita R, et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochemd Biophys Res Commun 2005; 334: 1121-6.
336. Schillinger U, Brill T, Rudolph C, et al. Advances in magnetofection - magnetically guided nucleic acid delivery. J Magn Magn Mater 2005; 293: 501-8.
337. Bae KH, Lee K, Kim C, Park TG. Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials 2011; 32: 176-84.